• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Texas Movement Disorder Specialists, PLLC, Georgetown, TX

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 3 of 3

  • Page:
  • 1

Levodopa Initiation or Dose Adjustments in TEMPO-4: A 58-Week Open-label Trial of Tavapadon for Treatment of PD

Author:Ondo, William   Hatcher, Meredith   Soileau, Michael   Eubanks, James   Nicholson, Tracy   Dhall, Rohit   

Session Name:S26: Movement Disorders: Clinical Trials and Therapeutics  

Topic:Movement Disorders  

Program Number:S26.007  

Author Institution:Houston Methodist Neurological Institute, Weill Cornell Medical School, Houston, TX  Texas Movement Disorder Specialists, Georgetown, TX  Texas Movement Disorder Specialists, PLLC, Georgetown, TX  AbbVie, Inc., North Chicago, IL  University of Arkansas for Medical Sciences, Little Rock, AR  

  • View Abstract
  • View Disclosure

Feasibility of an Entirely Remote, Decentralized, Phase 3 Trial of a Light Therapy Device for Parkinson’s Disease

Author:Hussain, Sarrah   Alessi-Fox, Christi   Kostrzebski, Melissa   Murphy, Kathryn   Porto, Michelle   Schmier, Katrina   McGarry, Andrew   Adams, Jamie   Agarwal, Pinky   Aldred, Jason   Andruska, Kristin   Baumgartner, Alexander   Farmer, Jill   Mehanna, Raja   Richard, Irene   Soileau, Michael   Swan, Matthew   Wyant, Kara   Hendrix, Kent   Hendrix, Suzanne   Adams, Dan   Dorsey, E. Ray   

Session Name:P2: Emerging Science 1  

Topic:Movement Disorders  

Program Number:P2.021  

Author Institution:University of California, San Francisco, Reseda, CA  University of Rochester, NY  Clintrex, TX  Evergreen Health, Kirkland, WA  Selkirk Neurology, WA  CMDC, Mountain View, CA  University of Colorado, Aurora, CO  Boro Neurology, Hopewell, NJ  University of Texas Health Science Center At Houston-McGovern Medical School, Houston, TX  Texas Movement Disorder Specialists, PLLC, Georgetown, TX  Mount Sinai Medical Center, New York, NY  University of Michigan, Neurology Dept, Ann Arbor, MI  Pentara Corporation, UT  Photopharmics, Inc., UT  Atria Research and Global Health Institute, NY  

  • View Abstract
  • View Disclosure

Switching to CREXONT® Improves “Good On” Time and Reduces Motor Fluctuations in Parkinson’s Disease: Interim Results from the Real-world ELEVATE-PD Phase Four Study

Author:Isaacson, Stuart   Jimenez Shahed, Joohi   Soileau, Michael   Holley, Andrew   Banisadr, Ghazal   Fisher, Stanley   Visser, Hester   Hauser, Robert   

Session Name:P3: Movement Disorders: Parkinson's Disease Management 1  

Topic:Movement Disorders  

Program Number:P3.001  

Author Institution:Parkinson's Dis & Mov Dis Ctr of Boca Raton, Boca Raton, FL  Icahn School of Medicine at Mount Sinai, New York City, NY  Texas Movement Disorder Specialists, PLLC, Georgetown, TX  Amneal Pharmaceuticals, Plano, TX  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Warren, NJ  Amneal Pharmaceuticals, NJ  Movement Disorders Center, Tampa, FL  

  • View Abstract
  • View Disclosure

Displaying 1 - 3 of 3

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com